News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Alfredo Addeo: The Phase 3 DeLLphi-304 trial met its primary endpoint
hug.ch
Apr 14, 2025, 03:45

Alfredo Addeo: The Phase 3 DeLLphi-304 trial met its primary endpoint

Alfredo Addeo, Head of Oncology Department at Geneva University Hospitals, shared a post on X:

“Breaking: The Phase 3 DeLLphi-304 trial met its primary endpoint: Imdelltra (tarlatamab-dlle) significantly improved overall survival vs SOC in SCLC patients post-platinum. A major step forward for this hard-to-treat disease. Look forward to seeing the data.”

Alfredo Addeo: The Phase 3 DeLLphi-304 trial met its primary endpoint

Alfredo Addeo cancer OncoDaily Oncology
Special Coverage
Blog
May 1, 2025, 20:49
Jennifer Bires: Patients Carrying Private Fears They Were Too Overwhelmed to Share
Blog
May 1, 2025, 20:14
NCI Center for Global Health Highlights Challenges of Conducting Cancer Trials in LMICs
Blog
May 1, 2025, 19:53
CCI4EU: A European Initiative Supporting Cancer Research and Innovation - ESO
Blog
May 1, 2025, 19:21
Rima Torosyan: Grateful to be part of the Retinoblastoma Workshop at the POEM Group’s 4th Scientific Meeting
Blog
May 1, 2025, 19:08
Jasmine Kamboj: Fantastic conversations on AI in Oncology with trailblazers
Blog
May 1, 2025, 18:56
Hadieh Eslampanah is Participating in the 17th CCI and SIOP Asia Riyadh 2025 Conference as a Board Member
Blog
May 1, 2025, 18:12
Alastair Lamb highlights BJUI session on AI and Medicolegal topics at AUA25
Blog
May 1, 2025, 18:05
Misty Dawn Shields: An amazing night at the "Evening of Promise" gala hosted by American Lung Association
Blog
May 1, 2025, 18:04
Karuna Ganesh reveals E. coli’s role in early-onset colorectal cancer Initiation at AACR25
Drugs
May 1, 2025, 17:54
Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers
Insight
May 1, 2025, 17:49
Miguel Bronchud shared insights on the tumor microenvironment in cancer progression
Opinion
May 1, 2025, 17:39
Daniel Flora: Letter to my new cancer patients - What I want you to know as we begin this journey